Cognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder by Helen Blair Simpson and others 2026-10-24
View more
Primary randomized augmentation trial; 100 adults maintained on an SRI, eight-week ERP/risperidone/placebo comparison.
Read the full article